OMI Pulse Earns ASCO Recognition for Quality Solution in Oncology

OMI Pulse Earns Esteemed ASCO Recognition
OMI Pulse has recently been recognized as an ASCO Recognized Quality Solution provider, a prestigious acknowledgment that showcases the company's unwavering dedication to high-quality data in pathway utilization for oncology care. This recognition enables oncology practices to efficiently submit pathway utilization data within the ASCO Certified framework, ultimately creating a seamless experience for health system and oncology practice partners.
Significance of ASCO Recognition
Receiving this acknowledgment is a testament to OMI Pulse’s commitment to enhancing patient care through quality data. The ASCO Recognized Quality Solution (RQS) program has been designed specifically to identify and endorse technology and data providers that consistently offer the best in quality data products and resources tailored for oncology practices.
Benefits of OMI Pulse as RQS Provider
By functioning within the ASCO Certified program, OMI Pulse aims to provide essential point-of-care decision support tools that align with ASCO’s criteria for high-quality clinical pathways in oncology. Dr. Andrew Pecora, CEO & Chairman of Outcomes Matter Innovations, emphasizes the importance of this technology, noting that it helps to make cancer care more affordable for patients while adhering to the highest quality standards.
The Journey to Becoming RQS Data Provider
To earn this recognition, OMI Pulse underwent a comprehensive validation process that scrutinized necessary data elements vital for effective clinical quality measurement. This process underscores OMI’s ongoing commitment to leveraging quality data to facilitate better patient outcomes.
Application for ASCO RQS Resources
Oncology practices looking to benefit from the comprehensive resources provided by ASCO RQS are encouraged to apply to become an RQS data provider. They can receive support and resources tailored to assist them in meeting ASCO Certified data requirements.
About Outcomes Matter Innovations
Founded in 2018, Outcomes Matter Innovations, LLC (OMI) is a forward-thinking company based in New Jersey. Their primary focus is to equip specialty physicians with real-time decision support technology designed to enhance patient treatment at the point of care, paired with innovative reimbursement models aimed at supporting value-based care programs. These initiatives are critically aimed at improving clinical quality outcomes while significantly lowering the overall cost of care.
Expanding Nationally
OMI is dedicated to building partnerships with a diverse range of specialty physicians across the country. The company works diligently on developing clinical treatment pathways that are integrated into their technology for medical conditions characterized by a high total cost of care and substantial variability in expenses, seeking to improve clinical outcomes and reduce unnecessary variations in treatment approaches.
Understanding RQS and ASCO Certified
The RQS program provides a framework for data providers to submit data regarding pathways essential for modern oncology practices. This initiative offers data vendors a unique platform to exhibit their commitment to data quality, facilitating smoother certification processes for practices utilizing OMI's innovations.
The Role of ASCO Certified
ASCO Certified represents a hallmark certification program, integrating ASCO and COA’s Oncology Medical Home standards. It certifies outpatient oncology group practices and healthcare systems that conform to comprehensive standards focused on delivering patient-centered care. The program allows practices to assess quality, outcomes, and utilization metrics drawn from electronic health records, insurance claims, patient satisfaction surveys, and evidence-backed treatment pathways.
Contact Information
For inquiries regarding OMI Pulse and ASCO RQS resources, please reach out:
Alison Brown
Phone: 860-965-9009
Email: [contact@omi.com]
Frequently Asked Questions
What is OMI Pulse?
OMI Pulse is a technology provider specializing in real-time decision support for oncology practices, helping enhance patient care.
What does ASCO Recognized Quality Solution (RQS) mean?
The ASCO RQS designation identifies providers that deliver high-quality data products beneficial to oncology practices.
Why is achieving ASCO recognition important?
This recognition underscores OMI Pulse's commitment to quality and supports oncology practices in meeting stringent data requirements.
How does the ASCO Certified program work?
ASCO Certified evaluates practices against comprehensive standards to certify their dedication to patient-centered care in oncology.
Who should contact OMI for more information?
Oncology practices interested in becoming an ASCO RQS data provider or learning about OMI's services should reach out directly for resources and guidance.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.